Sirolimus use improves cancer-free survival following transplantation: A single center 12-year analysis
Background: Sirolimus, is used in ~5% of all US transplant centers as part of a maintenance immunosuppression regimen following solid organ transplantation. In previous published results, we showed that the use of a Sirolimus-based, early steroid withdrawal immunosuppression regimen improved patient...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | Transplantation Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451959620300020 |